|
Coagulation
Citations 101-110 of 166 total displayed.
|
Past content
(since Sep 2000):
|
- Articles
Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus. Relationships to Cardiovascular Disease and Risk Factor Intervention
- Hoong Sern Lim, Andrew D. Blann, and Gregory Y.H. Lip
Circulation published May 10, 2004, doi:10.1161/01.CIR.0000129773.70647.94
[Abstract]
- Clinical Investigations and Reports
Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study
- P.E. Morange, C. Simon, M.C. Alessi, G. Luc, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, P. Ducimetiere, I. Juhan-Vague on behalf of the PRIME Study Group
Circulation 2004;109:1343-1348; published online before print as doi:10.1161/01.CIR.0000120705.55512.EC
[Abstract]
[Full text]
- Articles
Endothelial Cell Markers and the Risk of Coronary Heart Disease. The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study
- P. E. Morange, C. Simon, M. C. Alessi, G. Luc, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, P. Ducimetiere, I. Juhan-Vague on behalf of the PRIME Study Group
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000120705.55512.EC
[Abstract]
- Clinical Investigations and Reports
Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis: Results From a Multicenter Study in 47 Patients
- A.
 rámek, P. Bucciarelli, A.B. Federici, P.M. Mannucci, V. De Rosa, G. Castaman, M. Morfini, M.G. Mazzucconi, A. Rocino, M. Schiavoni, F.A. Scaraggi, J.H.C. Reiber, and F.R. Rosendaal
Circulation 2004;109:740-744, doi:10.1161/01.CIR.0000112567.53841.10
[Abstract]
[Full text]
- Clinical Investigations and Reports
Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary Syndromes
- Paolo Golino, Amelia Ravera, Massimo Ragni, Plinio Cirillo, Orlando Piro, and Massimo Chiariello
Circulation 2003;108:2864-2869; published online before print as doi:10.1161/01.CIR.0000105900.21445.3D
[Abstract]
[Full text]
- Articles
Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary Syndromes
- Paolo Golino, Amelia Ravera, Massimo Ragni, Plinio Cirillo, Orlando Piro, and Massimo Chiariello
Circulation published December 1, 2003, doi:10.1161/01.CIR.0000105900.21445.3D
[Abstract]
- Clinical Investigations and Reports
Sulfatides: Targets for Anti-Phospholipid Antibodies
- M. Merten, S. Motamedy, S. Ramamurthy, F.C. Arnett, and P. Thiagarajan
Circulation 2003;108:2082-2087; published online before print as doi:10.1161/01.CIR.0000095030.44185.6A
[Abstract]
[Full text]
- Articles
Sulfatides. Targets for Anti-Phospholipid Antibodies
- M. Merten, S. Motamedy, S. Ramamurthy, F. C. Arnett, and P. Thiagarajan
Circulation published October 6, 2003, doi:10.1161/01.CIR.0000095030.44185.6A
[Abstract]
- Clinical Investigations and Reports
Elevated Whole-Blood Tissue Factor Procoagulant Activity as a Marker of Restenosis After Percutaneous Transluminal Coronary Angioplasty and Stent Implantation
- Eralp Tutar, Muhit Ozcan, Mustafa Kilickap, Sadi Gülec, Omer Aras, Gulgun Pamir, Dervis Oral, Luke Dandelet, and Nigel S. Key
Circulation 2003;108:1581-1584; published online before print as doi:10.1161/01.CIR.0000091082.75419.9F
[Abstract]
[Full text]
- Articles
Elevated Whole-Blood Tissue Factor Procoagulant Activity as a Marker of Restenosis After Percutaneous Transluminal Coronary Angioplasty and Stent Implantation
- Eralp Tutar, Muhit Ozcan, Mustafa Kilickap, Sadi Gülec, Omer Aras, Gulgun Pamir, Dervis Oral, Luke Dandelet, and Nigel S. Key
Circulation published September 15, 2003, doi:10.1161/01.CIR.0000091082.75419.9F
[Abstract]
|
|
